Polaris Market Research Releases AI in Multiomics Market Outlook 2026-2034: AI-Powered Biological Data Analysis Accelerates Precision Medicine Innovation

New industry analysis projects strong growth in the AI in multiomics market through 2034 as pharmaceutical companies, research institutions, and healthcare organizations expand investments in AI-driven multiomics platforms, precision medicine, and biomarker discovery.

Market Size 2025	Forecast 2034	CAGR 2026-2034	Leading Region
USD 749.41 million	USD 6,021.56 million	26.05%	North America

Polaris Market Research & Consulting has released its AI in Multiomics Market Report 2026-2034. The market was valued at USD 749.41 million in 2025 and is projected to reach USD 6,021.56 million by 2034, registering a CAGR of 26.05% during the forecast period. The report emphasizes that growth in the market is due to increased adoption of artificial intelligence in multiomics data analysis, rising demand for precision medicine, and increased investment in genomics and life sciences research. Increasing applications in biomarker discovery, drug discovery, regenerative medicines, and organoid research are also aiding the growth of the market.

The healthcare sector, biopharma industry, and research organizations are increasingly using artificial intelligence-based multiomics platforms for the integration of genomics, transcriptomics, proteomics, metabolomics, and epigenomics data. AI helps in the faster discovery of disease biomarkers, finding drug targets, and personalized medicine development. Continuous advancements in machine learning, cloud bioinformatics, and spatial multiomics technologies are driving the market growth.

“AI technology adoption within multiomics has helped scientists perform analysis on complex biological data sets. The growing adoption of AI analytics is facilitating fast biomarker discovery, personalized medicine, and drug discovery in the healthcare industry." — Prajakta Bengale, Senior Analyst

AI in Multiomics Market Investment Signals 2026

Investment Theme	Market Signal	Business Implication
Precision Medicine	Growing demand for personalized therapies	Expands AI-enabled healthcare investments
AI-Based Drug Discovery	Rising pharmaceutical R&D spending	Accelerates biomarker and target discovery
Cloud Bioinformatics	Increasing adoption of cloud-based analytics	Supports scalable multiomics research
Regenerative Medicine	Growing stem cell and organoid research	Creates long-term market opportunities

Polaris Market Research Analysis

Three Market Developments Reshaping the AI in Multiomics Industry in 2026

AI is Accelerating Precision Medicine

Increasingly many healthcare providers and researchers are relying on the application of artificial intelligence technology to examine multiomics data to diagnose diseases and provide personalized treatments. The application of AI technology in biomarker discovery makes biological data analysis faster.

Multiomics Platforms are Transforming Drug Discovery

Artificial intelligence and multiomics technologies have been adopted by pharmaceutical companies to help identify targets for drug development and conduct clinical trials. Increased interest in genomics, proteomics, and spatial biology is adding to the rising market demand.

Regenerative Medicine is Creating New Growth Opportunities

Research activities in stem cell technology, tissue engineering, and organoids are fueling the demand for artificial intelligence-based multiomics platforms. Organizations are investing in advanced biological data analysis to support next-generation regenerative therapies.

Request a free sample copy or read the full market insights : AI in Multiomics Market Report

About the Polaris AI in Multiomics Market Report 2026-2034

The report provides a comprehensive analysis of market size, growth opportunities, technology trends, regional outlook, competitive landscape, and investment opportunities across the global AI in multiomics industry. The study supports pharmaceutical companies, biotechnology firms, research organizations, healthcare providers, AI software developers, investors, and corporate strategy teams in evaluating market opportunities and competitive positioning.

Report coverage: Market size and CAGR by component, omics type, deployment, application, and end user | Regional analysis across 5 regions with country-level breakdowns | 21 company profiles with financial benchmarking | Regulatory environment heatmap by country | Technology and innovation landscape | PDF and Excel formats | Customization available by country, region, and segment

Key Companies Profiled

10x Genomics
Agilent Technologies
Bayer Crop Science
Bio Rad Laboratories, Inc.
BGI Group
Bruker Corporation
Charles River Laboratories
Corteva Agriscience
Danaher Corporation (Beckman Coulter)
DNAnexus, Inc.
F. Hoffmann La Roche Ltd.
Fabric Genomics, Inc.
Illumina, Inc.
Inari Agriculture
Microsoft Corporation
NVIDIA Corporation
PerkinElmer, Inc.
QIAGEN N.V.
SOPHiA GENETICS
Tempus AI, Inc.
Thermo Fisher Scientific Inc.

Market Segments Covered in the AI in Multiomics Market Report

By Component Outlook (Revenue, USD Million, 2021–2034)

Software
Hardware
Services

By Omics Type Outlook (Revenue, USD Million, 2021–2034)

Genomics
Transcriptomics
Proteomics
Metabolomics
Epigenomics
Spatial Multiomics

By Deployment Outlook (Revenue, USD Million, 2021–2034)

Cloud
On-Premises
Hybrid

By Application Outlook (Revenue, USD Million, 2021–2034)

Drug Discovery & Development
Precision & Personalized Medicine
Biomarker Discovery
Clinical Diagnostics
Agricultural Research
Others

By End User Outlook (Revenue, USD Million, 2021–2034)

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Healthcare Providers
Contract Research Organizations (CROs)
Others

By Regional Outlook (Revenue, USD Million, 2021-2034)

North America

US
Canada

Europe

Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe

Asia Pacific

China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific

Middle East & Africa

Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa

Latin America

Mexico
Brazil
Argentina
Rest of Latin America